Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Nutra Pharma manufactures first commercial batch of Cobroxin

Nutra Pharma manufactures first commercial batch of Cobroxin

New drug combination releives neuropathic pain and improves sleep

New drug combination releives neuropathic pain and improves sleep

Drug registration process for Nutra Pharma's pain reliever begins

Drug registration process for Nutra Pharma's pain reliever begins

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

Results from Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 announced

Results from Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 announced

FDA approves Supplemental New Drug Application for DOXIL

FDA approves Supplemental New Drug Application for DOXIL

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Millennium's sNDA to be reviewed by the FDA

Millennium's sNDA to be reviewed by the FDA

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference

New director appointed at the Saint John’s Neuroscience Institute

New director appointed at the Saint John’s Neuroscience Institute

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S.

Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S.

Endo Pharmaceuticals Solutions announces the beginning of cash tender offer

Endo Pharmaceuticals Solutions announces the beginning of cash tender offer

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Retigabine's Phase IIa clinical trial preliminary results announced

Retigabine's Phase IIa clinical trial preliminary results announced

Nutra Pharma launches Cobroxin for chronic pain relief

Nutra Pharma launches Cobroxin for chronic pain relief

Inhibitex reports Q2 2009 financials

Inhibitex reports Q2 2009 financials

Transcranial MR-guided focused ultrasound for brain disorders a step closer

Transcranial MR-guided focused ultrasound for brain disorders a step closer